Cite Filings / STOK / 0001950047-25-009261

Feed Companies Filings Check

Sign in

144

Sale of Securities

Stoke Therapeutics, Inc. Filed 2025-11-24 Acc 0001950047-25-009261

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2025-12-05 144 Sale of Securities
2025-11-26 4 Director sold 40,472 shares at $29.72 ($1,202,719)
2025-11-24 144 Sale of Securities
2025-11-18 4 Director sold 40,472 shares at an average $26.98 ($1,092,058)
2025-11-14 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…